Martin D. Fleming

University of Tennessee Health Science Center — United States

Medicine · Health Sciences

23h-index2.8kcitations80works15.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cutaneous Melanoma Detection and Management(25), CAR-T cell therapy research(16), Melanoma and MAPK Pathways(13), Gastric Cancer Management and Outcomes(8), Breast Cancer Treatment Studies(6)

Publications79 total

Neoadjuvant Chemoradiation Versus Chemotherapy for Esophageal Cancer: A Histology-Stratified Update Meta-Analysis of Randomized Controlled Trials
Annals of Surgical Oncology·2026· 1 cited
Development of Entrustable Professional Activities for Complex General Surgical Oncology
Annals of Surgical Oncology·2025· 1 cited
Understanding Improvements in Disparities in Breast Cancer Care in Memphis, Tennessee: A Comparison of Two Time Cohorts
The American Surgeon·2025
BEYOND AI EXPOSURE: WHICH TASKS ARE COST-EFFECTIVE TO AUTOMATE WITH COMPUTER VISION?
SSRN Electronic Journal·2025· 2 citedOpen Access
Secretory Carcinoma in the Axilla with Extensive Lymph Node Metastases: A Case Report
Case Reports in Clinical Medicine·2025Open Access
A molecular switch from tumor suppressor to oncogene in ER+ve breast cancer: Role of androgen receptor, JAK-STAT, and lineage plasticity
Proceedings of the National Academy of Sciences·2024· 6 citedOpen Access
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024
Journal of the National Comprehensive Cancer Network·2024· 100 cited
A Model for Estimating the Economic Costs of Computer Vision Systems That Use Deep Learning
Proceedings of the AAAI Conference on Artificial Intelligence·2024· 7 citedOpen Access
Beyond AI Exposure: Which Tasks are Cost-Effective to Automate with Computer Vision?
SSRN Electronic Journal·2024· 21 citedOpen Access
Identification of a targetable JAK-STAT enriched androgen receptor and androgen receptor splice variant positive triple-negative breast cancer subtype
Cell Reports·2023· 12 citedOpen Access
Early-stage breast cancer treatment disparities in the Midsouth: Has anything changed?
The American Journal of Surgery·2023· 1 cited
Understanding Improvements in Disparities in Breast Cancer Care in Memphis, Tennessee: A Comparison of Two Time Cohorts
International Journal of Cancer Care and Delivery·2023Open Access
Principles and methods of randomization in research
Translational Surgery·2023· 3 cited
List of contributors
Translational Surgery·2023
Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection
Journal for ImmunoTherapy of Cancer·2022· 14 citedOpen Access
Visceral angiosarcoma: A nationwide analysis of treatment factors and outcomes
Journal of Surgical Oncology·2022· 5 cited
Expanded evidence that the 31-gene expression profile test provides clinical utility for melanoma management in a multicenter study
Current Medical Research and Opinion·2022· 17 citedOpen Access
Enterprise Payments with Central Bank Digital Currency
Springer series in supply chain management·2022
Impact of adjuvant therapies following surgery for anal melanoma
The American Journal of Surgery·2021· 11 cited
Integrating 31-Gene Expression Profiling With Clinicopathologic Features to Optimize Cutaneous Melanoma Sentinel Lymph Node Metastasis Prediction
JCO Precision Oncology·2021· 51 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Jeremiah L. Deneve(10), John T. Vetto(9), Dominick J. DiMaio(8), Brian Gastman(8), Julie R. Lange(8), Anthony J. Olszanski(8), Merrick I. Ross(8), Susan M. Swetter(8), Nicole R. McMillian(8), April K.S. Salama(7), Daniel G. Coit(6), William E. Carson(6), Ryan C. Fields(6), Valerie Guild(6), Joseph J. Skitzki(6), Giorgos C. Karakousis(6), Robert W. Cook(6), Paxton V. Dickson(6), John A. Thompson(5), Gregory A. Daniels(5)